Molecular Restoration Through Replacement Therapies: Current Advances and Future Directions in Treating Diseases
DNA and Cell Biology · 2026
DOI: 10.1177/10445498261473080 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift DNA and Cell Biology, 2026. Verfasst von Moslem Naderian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Genetic Therapy. Die Arbeit nennt 210 Literaturangaben. Gefördert von: Shiraz University of Medical Sciences, Shiraz, Iran.
Abstract (Originalsprache)
Replacement therapy is an advanced therapeutic approach for diseases caused by molecular deficits. It aims to restore normal physiology by replacing deficient molecules such as enzymes, proteins, genes, or other molecules. Here, we discuss different modalities, including protein replacement, gene therapy, messenger RNA (mRNA) replacement, noncoding RNA (ncRNA) therapies, cell replacement, and gene editing, aimed at addressing and treating the fundamental genetic defects underlying a range of diseases. These therapies could have potentially curative and disease-modifying effects when used to directly replace deficient or dysfunctional components, addressing the inherent limitations of conventional therapies, such as off-target effects and control of disease-related symptoms. Some replacement therapies, such as protein therapy, gene therapy, and cell therapy, are already approved for clinical use, while emerging approaches—including mRNA therapy, ncRNA therapy, and gene editing—remain primarily in the preclinical or clinical trial stages. To achieve broad clinical translation of these emerging approaches, key challenges, including delivery, safety, specificity, and ethical concerns, must be addressed. This review provides an overview of the existing modalities of replacement therapies, their mechanisms of action, and future directions for improving clinical translation, efficacy, and accessibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Biomedical and Nutritional Sciences, University of Massachusetts Lowell, Lowell, Massachusetts, USA.
- Laboratory for Functional Foods and Human Health, Center for Excellence in Post-Harvest Technologies, North Carolina Research Campus, North Carolina Agricultural and Technical State University, Kannapolis, North Carolin…
- Department of Medicinal Chemistry, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Medical Biotechnology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Issa Sadeghian
Förderung
- Shiraz University of Medical Sciences, Shiraz, Iran
Zitieren
APA
Naderian, M., Davoudi, E., Hafez Ghoran, S., Sadeghian, S., Goudarzi, K., & Sadeghian, I. (2026). Molecular Restoration Through Replacement Therapies: Current Advances and Future Directions in Treating Diseases. DNA and Cell Biology. https://doi.org/10.1177/10445498261473080
Vancouver
Naderian M, Davoudi E, Hafez Ghoran S, Sadeghian S, Goudarzi K, Sadeghian I. Molecular Restoration Through Replacement Therapies: Current Advances and Future Directions in Treating Diseases. DNA and Cell Biology. 2026. doi:10.1177/10445498261473080
BibTeX
@article{Naderian2026,
author = {Naderian, Moslem and Davoudi, Elham and Hafez Ghoran, Salar and Sadeghian, Sara and Goudarzi, Kamran and Sadeghian, Issa},
title = {Molecular Restoration Through Replacement Therapies: Current Advances and Future Directions in Treating Diseases},
journal = {DNA and Cell Biology},
year = {2026},
doi = {10.1177/10445498261473080}
}
EUVIMED